| 000 | 01724 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515012511.0 | ||
| 264 | 0 | _c20060503 | |
| 008 | 200605s 0 0 eng d | ||
| 022 | _a0742-3071 | ||
| 024 | 7 |
_a10.1111/j.1464-5491.2005.01717.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZeggini, E | |
| 245 | 0 | 0 |
_aExamining the relationships between the Pro12Ala variant in PPARG and Type 2 diabetes-related traits in UK samples. _h[electronic resource] |
| 260 |
_bDiabetic medicine : a journal of the British Diabetic Association _cDec 2005 |
||
| 300 |
_a1696-700 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAge of Onset |
| 650 | 0 | 4 | _aAlanine |
| 650 | 0 | 4 | _aAmino Acid Substitution |
| 650 | 0 | 4 | _aBody Mass Index |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGenetic Predisposition to Disease _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPPAR gamma _xgenetics |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 | _aPolymorphism, Restriction Fragment Length |
| 650 | 0 | 4 |
_aPolymorphism, Single Nucleotide _xgenetics |
| 650 | 0 | 4 | _aUnited Kingdom |
| 700 | 1 | _aParkinson, J R C | |
| 700 | 1 | _aHalford, S | |
| 700 | 1 | _aOwen, K R | |
| 700 | 1 | _aWalker, M | |
| 700 | 1 | _aHitman, G A | |
| 700 | 1 | _aLevy, J C | |
| 700 | 1 | _aSampson, M J | |
| 700 | 1 | _aFrayling, T M | |
| 700 | 1 | _aHattersley, A T | |
| 700 | 1 | _aMcCarthy, M I | |
| 773 | 0 |
_tDiabetic medicine : a journal of the British Diabetic Association _gvol. 22 _gno. 12 _gp. 1696-700 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1464-5491.2005.01717.x _zAvailable from publisher's website |
| 999 |
_c16018532 _d16018532 |
||